Ondansetron for postoperative nausea and vomiting

By Cohen Ira Todd  

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 571-578

Future Medicine

Access to resources Recommend Favorite

Does previous chemotherapy‐induced nausea and vomiting predict postoperative nausea and vomiting?

By  

ACTA ANAESTHESIOLOGICA SCANDINAVICA, Vol. 59, Iss. 9, 2015-10 ,pp. : 1145-1153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed

By Erazo Valle Aura   Wisniewski Tami   Figueroa Vadillo Jasmin Isabel   Burke Thomas A.   Martinez Corona Roberto  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2403-2410

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-induced nausea and vomiting in Portugal: incidence versus healthcare provider estimations and effect on quality of life

By Dinis Joséé   Wisniewski Tami   Moreira Antóónio   Raposo Joãão   Ma Larry   Burke Thomas A  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 595-602

Future Medicine

Access to resources Recommend Favorite

Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy

By Bloch J.   Rixe O.   Meric J. B.   Delgado A.   Khayat D.  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1763-1771

Informa Healthcare

Access to resources Recommend Favorite